I think we get info on C and D and maybe F. F being possible patent acceptance from last November applications. Uplist I would hope is later after price is up past .20. JV or merger I would think is after phase 1, unless all patents or most get accepted and they get orphan drug status (which I thought I read is something that can be sold for a ton of money)